87 related articles for article (PubMed ID: 8031450)
1. Synthesis, DNA binding, sequence preference and biological evaluation of minor groove-selective N1-alkoxyalkyl-bis-benzimidazoles.
Wang H; Gupta R; Lown JW
Anticancer Drug Des; 1994 Jun; 9(3):153-60. PubMed ID: 8031450
[TBL] [Abstract][Full Text] [Related]
2. DNA alkylation by minor groove-binding N1-alkoxyalkyl-bis-benzimidazoles.
Gupta R; Huang L; Wang H; Lown JW
Anticancer Drug Des; 1995 Sep; 10(6):451-61. PubMed ID: 7575987
[TBL] [Abstract][Full Text] [Related]
3. DNA sequence-selective binding of head-to-tail linked bis-lexitropsins: relation of phasing to cytotoxic potency.
Guo D; Gupta R; Lown JW
Anticancer Drug Des; 1993 Oct; 8(5):369-97. PubMed ID: 8251044
[TBL] [Abstract][Full Text] [Related]
4. Molecular recognition between oligopeptides and nucleic acids: DNA sequence specificity and binding properties of thiazole-lexitropsins incorporating the concepts of base site acceptance and avoidance.
Rao KE; Shea RG; Yadagiri B; Lown JW
Anticancer Drug Des; 1990 Feb; 5(1):3-20. PubMed ID: 2156516
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and DNA interactions of benzimidazole dications which have activity against opportunistic infections.
Lombardy RL; Tanious FA; Ramachandran K; Tidwell RR; Wilson WD
J Med Chem; 1996 Mar; 39(7):1452-62. PubMed ID: 8691476
[TBL] [Abstract][Full Text] [Related]
6. Molecular determinants for DNA minor groove recognition: design of a bis-guanidinium derivative of ethidium that is highly selective for AT-rich DNA sequences.
Bailly C; Arafa RK; Tanious FA; Laine W; Tardy C; Lansiaux A; Colson P; Boykin DW; Wilson WD
Biochemistry; 2005 Feb; 44(6):1941-52. PubMed ID: 15697219
[TBL] [Abstract][Full Text] [Related]
7. Sequence-selective targeting of long stretches of the DNA minor groove by a novel dimeric bis-benzimidazole.
Joubert A; Sun XW; Johansson E; Bailly C; Mann J; Neidle S
Biochemistry; 2003 May; 42(20):5984-92. PubMed ID: 12755600
[TBL] [Abstract][Full Text] [Related]
8. Bis-benzimidazole anticancer agents: targeting human tumour helicases.
Soderlind KJ; Gorodetsky B; Singh AK; Bachur NR; Miller GG; Lown JW
Anticancer Drug Des; 1999 Feb; 14(1):19-36. PubMed ID: 10363025
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents.
Lee M; Rhodes AL; Wyatt MD; Forrow S; Hartley JA
Anticancer Drug Des; 1993 Jun; 8(3):173-92. PubMed ID: 8517912
[TBL] [Abstract][Full Text] [Related]
10. DNA sequence dependent monomer-dimer binding modulation of asymmetric benzimidazole derivatives.
Tanious FA; Hamelberg D; Bailly C; Czarny A; Boykin DW; Wilson WD
J Am Chem Soc; 2004 Jan; 126(1):143-53. PubMed ID: 14709078
[TBL] [Abstract][Full Text] [Related]
11. DNA recognition by lexitropsins, minor groove binding agents.
Lown JW
J Mol Recognit; 1994 Jun; 7(2):79-88. PubMed ID: 7826677
[TBL] [Abstract][Full Text] [Related]
12. Pyrrolobenzimidazoles linked to heterocycles and peptides. Design of DNA base pair specific phosphate hydrolyzing agents and novel cytotoxic agents.
Ghodousi A; Huang X; Cheng Z; Skibo EB
J Med Chem; 2004 Jan; 47(1):90-100. PubMed ID: 14695823
[TBL] [Abstract][Full Text] [Related]
13. Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: synthesis, DNA sequence specificity and biological evaluation.
Gupta R; Liu J; Xie G; Lown JW
Anticancer Drug Des; 1996 Dec; 11(8):581-96. PubMed ID: 9022747
[TBL] [Abstract][Full Text] [Related]
14. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles.
Atwell GJ; Fan JY; Tan K; Denny WA
J Med Chem; 1998 Nov; 41(24):4744-54. PubMed ID: 9822545
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of Hoechst 33258 analogues.
Gupta R; Wang H; Huang L; Lown JW
Anticancer Drug Des; 1995 Jan; 10(1):25-41. PubMed ID: 7535056
[TBL] [Abstract][Full Text] [Related]
16. Psoralen--lexitropsin hybrids: DNA sequence selectivity of photoinduced cross-linking from MPE footprinting and exonuclease III stop assay, and mode of binding from electric linear dichroism.
Rao KE; Gosselin G; Mrani D; Périgaud C; Imbach JL; Bailly C; Hénichart JP; Colson P; Houssier C; Lown JW
Anticancer Drug Des; 1994 Jun; 9(3):221-37. PubMed ID: 8031454
[TBL] [Abstract][Full Text] [Related]
17. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and anti-tumor evaluation of novel symmetrical bis-benzimidazoles.
Yang YH; Cheng MS; Wang QH; Nie H; Liao N; Wang J; Chen H
Eur J Med Chem; 2009 Apr; 44(4):1808-12. PubMed ID: 18762358
[TBL] [Abstract][Full Text] [Related]
19. DNA minor groove binding-directed poisoning of human DNA topoisomerase I by terbenzimidazoles.
Xu Z; Li TK; Kim JS; LaVoie EJ; Breslauer KJ; Liu LF; Pilch DS
Biochemistry; 1998 Mar; 37(10):3558-66. PubMed ID: 9521677
[TBL] [Abstract][Full Text] [Related]
20. Minor groove-directed and intercalative ligand-DNA interactions in the poisoning of human DNA topoisomerase I by protoberberine analogs.
Pilch DS; Yu C; Makhey D; LaVoie EJ; Srinivasan AR; Olson WK; Sauers RR; Breslauer KJ; Geacintov NE; Liu LF
Biochemistry; 1997 Oct; 36(41):12542-53. PubMed ID: 9376359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
